Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Hematology/Oncology Clinics of North America|June 27, 2020
Immunomodulatory Agents in Follicular LymphomaLoic Ysebaert, Franck Morschhauser
Current Opinion in Oncology|July 18, 2014
Bruton's tyrosine kinase inhibitors: lessons learned from bench-to-bedside (first) studiesLoic Ysebaert, Anne-Sophie Michallet
Leukemia & Lymphoma|June 25, 2011
Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemiaAnne-Sophie Michallet, Julien Rossignol, Bruno Cazin, et al.
International Journal of Nursing Studies|February 26, 2011
Effectiveness of telephone support during chemotherapy in patients with diffuse large B cell lymphoma: the Ambulatory Medical Assistance (AMA) experienceGisèle Compaci, Loic Ysebaert, Lucie Obéric, et al.
Leukemia & Lymphoma|January 2, 2025
The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemiaLoic Ysebaert, Pierre-Luc Mouchel, Camille Laurent, et al.
Leukemia & Lymphoma|October 26, 2011
Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cellsCecile Liffraud, Anne Quillet-Mary, Jean-Jacques Fournié, et al.
Cancers|November 12, 2013
Cancer stem cells of differentiated B-cell malignancies: models and consequencesEmilie Gross, Anne Quillet-Mary, Loic Ysebaert, et al.
British Journal of Haematology|June 23, 2026
Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based studyYoann Zelmat, Loic Ysebaert, Paul Gautier, et al.
Pageof 7